Tag Archives: PRTO

Top 10 Clean Energy Stocks To Invest In 2019

Related CLNE 20 Biggest Mid-Day Losers For Friday Mid-Day Market Update: ConforMIS Gains Following Strong Q3 Results; MDC Partners Shares Drop Clean Energy Fuels Corp. – Bridge Funding For A Bridge Fuel (Seeking Alpha)
Related FRO Earnings Scheduled For November 29, 2016 Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Misses Estimates Frontline's (FRO) CEO Robert McLeod on Q3 2016 Results – Earnings Call Transcript (Seeking Alpha)

 

Toward the end of trading Wednesday, the Dow traded down 0.35 percent to 18,388.83 while the NASDAQ declined 0.25 percent to 5,209.89. The S&P also fell, dropping 0.36 percent to 2,168.24.

Leading and Lagging Sectors

Wednesday afternoon, non-cyclical consumer goods & services shares gained by 0.10 percent..

In trading on Wednesday, energy shares fell by 1.72 percent. Meanwhile, top losers in the sector included Clean Energy Fuels Corp (NASDAQ: CLNE), down 5 percent, and Frontline Ltd. (NYSE: FRO), down 7 percent.

Top 10 Clean Energy Stocks To Invest In 2019: Plum Creek Timber Company, Inc.(PCL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Plum Creek Timber (NYSE:PCL) has trended positive on Tuesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plum Creek Timber earned a daily sentiment score of 0.37 on Accern’s scale. Accern also gave media stories about the industrial goods maker an impact score of 45.0964567289057 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Media stories about Plum Creek Timber (NYSE:PCL) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Plum Creek Timber earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news coverage about the industrial goods maker an impact score of 46.0048348022167 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Clean Energy Stocks To Invest In 2019: Allstate Corporation (ALL)

Advisors’ Opinion:

  • [By Logan Wallace]

    DF Dent & Co. Inc. lessened its stake in shares of Allstate Corp (NYSE:ALL) by 2.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 40,677 shares of the insurance provider’s stock after selling 868 shares during the period. DF Dent & Co. Inc.’s holdings in Allstate were worth $3,713,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Zurich Insurance Group Ltd FI lessened its position in shares of Allstate Corp (NYSE:ALL) by 22.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,833 shares of the insurance provider’s stock after selling 16,753 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Allstate were worth $5,278,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Allstate (ALL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Invest In 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Top 10 Clean Energy Stocks To Invest In 2019: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By ]

    “Companies ranging from Action Alerts PLUS holding Microsoft (MSFT)  to heavy-truck maker Paccar (PCAR)  have over the years declared so-called ‘special dividends’ — one-time extra payments to shareholders. With the new U.S. tax law granting corporations a limited window to repatriate overseas profits at low tax rates, many companies might use the extra cash for special dividends. Let’s discuss how this impacts income investors,” writes Real Money Pro columnist Christopher Versace.

  • [By Ethan Ryder]

    KBC Group NV increased its position in shares of Paccar (NASDAQ:PCAR) by 9.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,983 shares of the company’s stock after purchasing an additional 7,832 shares during the quarter. KBC Group NV’s holdings in Paccar were worth $6,153,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D bought a new position in shares of Paccar (NASDAQ:PCAR) in the 1st quarter, Holdings Channel reports. The fund bought 160,000 shares of the company’s stock, valued at approximately $10,587,000.

Top 10 Clean Energy Stocks To Invest In 2019: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PRA Group (NASDAQ:PRAA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Monday.

  • [By Logan Wallace]

    Carillon Tower Advisers Inc. raised its stake in PRA Group (NASDAQ:PRAA) by 706.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 84,032 shares of the business services provider’s stock after buying an additional 73,617 shares during the quarter. Carillon Tower Advisers Inc. owned about 0.19% of PRA Group worth $3,193,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Pra Group Inc (NASDAQ:PRAA) SVP Christopher D. Lagow sold 1,474 shares of the stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $37.70, for a total value of $55,569.80. Following the transaction, the senior vice president now owns 18,273 shares of the company’s stock, valued at $688,892.10. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Dan Caplinger]

    Collecting unpaid debts is a big business, and although there are many small players in the industry, some relatively large companies have sought to build scale in order to be as efficient as possible. PRA Group (NASDAQ:PRAA) has become a leader in debt collection, but what’s especially surprising is that even in a strong economy featuring low unemployment rates and steadily rising wage growth, the company has started to see some favorable trends in its collection activity.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Pra Group (PRAA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Invest In 2019: Alder BioPharmaceuticals, Inc.(ALDR)

Advisors’ Opinion:

  • [By Max Byerly]

    Bioblast Pharma (NASDAQ: ALDR) and Alder Biopharmaceuticals (NASDAQ:ALDR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

  • [By Stephan Byrd]

    BidaskClub cut shares of Alder Biopharmaceuticals (NASDAQ:ALDR) from a strong-buy rating to a buy rating in a report released on Tuesday.

    A number of other equities research analysts have also weighed in on the company. Goldman Sachs Group initiated coverage on Alder Biopharmaceuticals in a research report on Tuesday, April 24th. They set a neutral rating and a $17.00 price objective on the stock. Mizuho restated a buy rating and set a $29.00 price objective on shares of Alder Biopharmaceuticals in a research report on Wednesday, March 28th. Cowen set a $23.00 price target on Alder Biopharmaceuticals and gave the company a buy rating in a research report on Monday, February 26th. Leerink Swann reiterated an outperform rating on shares of Alder Biopharmaceuticals in a research report on Sunday, March 4th. Finally, Zacks Investment Research lowered Alder Biopharmaceuticals from a hold rating to a sell rating in a research report on Tuesday, May 1st. One analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company. Alder Biopharmaceuticals currently has an average rating of Buy and a consensus target price of $26.33.

  • [By Ethan Ryder]

    Alder Biopharmaceuticals (NASDAQ:ALDR) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Monday.

  • [By Ethan Ryder]

    Needham & Company LLC assumed coverage on shares of Alder Biopharmaceuticals (NASDAQ:ALDR) in a report issued on Wednesday. The brokerage issued a buy rating and a $28.00 price objective on the biopharmaceutical company’s stock.

Top 10 Clean Energy Stocks To Invest In 2019: Cincinnati Financial Corporation(CINF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Swiss National Bank lowered its holdings in Cincinnati Financial (NASDAQ:CINF) by 13.6% in the first quarter, HoldingsChannel reports. The firm owned 498,032 shares of the insurance provider’s stock after selling 78,400 shares during the quarter. Swiss National Bank’s holdings in Cincinnati Financial were worth $36,984,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Oppenheimer & Co. Inc. decreased its position in Cincinnati Financial Co. (NASDAQ:CINF) by 5.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,145 shares of the insurance provider’s stock after selling 914 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Cincinnati Financial were worth $1,013,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its position in Cincinnati Financial Co. (NASDAQ:CINF) by 6.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 58,582 shares of the insurance provider’s stock after buying an additional 3,527 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Cincinnati Financial were worth $4,350,000 at the end of the most recent quarter.

Top 10 Clean Energy Stocks To Invest In 2019: Keryx Biopharmaceuticals, Inc.(KERX)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) dropped nearly 20% last month, according to data from S&P Global Market Intelligence. The pharma company announced second-quarter and first-half 2018 results that included disappointing sales revenue for its only drug, Auryxia. As a result, sales lagged behind consensus estimates despite delivering strong year-over-year growth.

  • [By Shane Hupp]

    ILLEGAL ACTIVITY WARNING: “Bank of New York Mellon Corp Sells 69,607 Shares of Keryx Biopharmaceuticals (KERX)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4158332/bank-of-new-york-mellon-corp-sells-69607-shares-of-keryx-biopharmaceuticals-kerx.html.

  • [By Shane Hupp]

    Keryx Biopharmaceuticals (NASDAQ:KERX)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Thursday. They currently have a $9.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 174.39% from the stock’s current price.

  • [By Stephan Byrd]

    Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) have received a consensus rating of “Hold” from the eight brokerages that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $6.00.

Top 10 Clean Energy Stocks To Invest In 2019: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By Motley Fool Transcription]

    Cboe Global Markets, Inc. (NYSEMKT:CBOE)Q4 2018 Earnings Conference CallFeb. 8, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Sean Williams]

    But times have changed, the virtual-currency market has matured a bit, and institutional investors have had a means to bet on the crypto market in a more traditional sense over the past couple of months. By this, I mean that both the CME Group and CBOE Global Markets (NASDAQ:CBOE) have offered bitcoin futures on their trading platforms since December, providing a more traditional avenue for Wall Street to place its bets.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Cboe Global Markets Inc (NASDAQ:CBOE) by 23.3% in the first quarter, Holdings Channel reports. The institutional investor owned 110,676 shares of the financial services provider’s stock after selling 33,675 shares during the quarter. State of Tennessee Treasury Department’s holdings in Cboe Global Markets were worth $12,628,000 as of its most recent filing with the SEC.

Top 10 Clean Energy Stocks To Invest In 2019: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from MarketFoolery, host Chris Hill and Foolish investor-at-large Tim Hansen consider the annual letter released last week by billionaire investing guru Howard Marks of Oaktree Capital (NYSE:OAK). In it, he expressed concern about the number of questionable deals happening in this low interest rate environment, as an excess of optimism and high risk-tolerance send capital toward assets it should probably shun at current prices.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA
    USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90%
    The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    Data on farm prices for the recent week will be released at 3:00 p.m. ET.
    ANALYST RATINGS
    Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy
    Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight
    Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform
    KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Daniel Miller, Jordan Wathen, and Jeremy Bowman]

    When it comes to dividend stocks, Coca-Cola Company (NYSE:KO) is a household name. In fact, the beverage giant just approved its 57th consecutive annual dividend increase, bumping it up to $0.40 per share and a juicy yield of 3.5%. But if investors are looking for even bigger dividend yields for their portfolios, three Motley Fool contributors suggest taking a peek at Macy’s (NYSE:M), Oaktree Capital Group (NYSE:OAK), and General Motors (NYSE:GM). Here’s why.

  • [By Motley Fool Staff]

    In this segment of Motley Fool Money, host Chris Hill asks senior analysts Jason Moser, Matt Argersinger, and Ron Gross to share which companies have been interesting them lately. Their responses run the investing gamut: alternative asset management firm Oaktree Capital (NYSE:OAK), sporting goods specialist Callaway Golf (NYSE:ELY), and media empire Disney (NYSE:DIS).

  • [By Logan Wallace]

    Oaktree Capital Group LLC (NYSE:OAK) Director Larry W. Keele sold 8,333 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $41.40, for a total transaction of $344,986.20. Following the completion of the transaction, the director now owns 8,656 shares in the company, valued at $358,358.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Anders Bylund, Timothy Green, and Brian Feroldi]

    Read on to see why our panelists suggest picking up Applied Optoelectronics (NASDAQ:AAOI), Oaktree Capital (NYSE:OAK), and Q2 Holdings (NYSE:QTWO) right now.

Top 10 High Tech Stocks To Buy For 2019

COB and CEO of Facebook Inc (NASDAQ:FB) Mark Zuckerberg sold 248,984 shares of FB on 08/15/2017 at an average price of $170.69 a share. The total sale was $42.5 million.

Facebook Inc is the world’s largest online social network. Its products are Facebook, Instagram, Messenger, WhatsApp, and Oculus. Its products enable people to connect and share through mobile devices and personal computers. Facebook Inc has a market cap of $493.71 billion; its shares were traded at around $170.00 with a P/E ratio of 36.78 and P/S ratio of 15.12. Facebook Inc had annual average EBITDA growth of 40.60% over the past five years.

CEO Recent Trades:

COB and CEO, 10% Owner Mark Zuckerberg sold 248,984 shares of FB stock on 08/15/2017 at the average price of $170.69. The price of the stock has decreased by 0.4% since.

Directors and Officers Recent Trades:

VP Marketing & Bus. Part. David B. Fischer sold 50,533 shares of FB stock on 08/10/2017 at the average price of $169.95. The price of the stock has increased by 0.03% since.VP and General Counsel Colin Stretch sold 750 shares of FB stock on 08/08/2017 at the average price of $171.88. The price of the stock has decreased by 1.09% since.Chief Technology Officer Michael Todd Schroepfer sold 37,963 shares of FB stock on 08/08/2017 at the average price of $171.98. The price of the stock has decreased by 1.15% since.Chief Product Officer Christopher K Cox sold 16,000 shares of FB stock on 08/07/2017 at the average price of $169.95. The price of the stock has increased by 0.03% since.VP and General Counsel Colin Stretch sold 750 shares of FB stock on 08/01/2017 at the average price of $169.93. The price of the stock has increased by 0.04% since.

For the complete insider trading history of FB, click here

Top 10 High Tech Stocks To Buy For 2019: Oriental Financial Group Inc.(OFG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Engineers Gate Manager LP increased its stake in shares of OFG Bancorp (NYSE:OFG) by 62.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,455 shares of the bank’s stock after buying an additional 29,451 shares during the period. Engineers Gate Manager LP’s holdings in OFG Bancorp were worth $799,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Bank of Marin Bancorp (NASDAQ: BMRC) and OFG Bancorp (NYSE:OFG) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

  • [By Joseph Griffin]

    Stevens Capital Management LP purchased a new stake in shares of OFG Bancorp (NYSE:OFG) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 16,250 shares of the bank’s stock, valued at approximately $170,000.

  • [By Ethan Ryder]

    OFG Bancorp (NYSE:OFG) will release its earnings data before the market opens on Friday, July 20th. Analysts expect OFG Bancorp to post earnings of $0.23 per share for the quarter.

  • [By Max Byerly]

    Shares of OFG Bancorp (NYSE:OFG) dropped 6.3% during trading on Monday . The company traded as low as $16.45 and last traded at $16.50. Approximately 794,358 shares changed hands during mid-day trading, an increase of 153% from the average daily volume of 313,807 shares. The stock had previously closed at $17.60.

  • [By Lisa Levin]

    Friday afternoon, the financial shares climbed 0.11 percent. Meanwhile, top gainers in the sector included Farmers Capital Bank Corporation (NASDAQ: FFKT), up 16 percent, and OFG Bancorp (NYSE: OFG), up 10 percent.

Top 10 High Tech Stocks To Buy For 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Top 10 High Tech Stocks To Buy For 2019: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

  • [By Jon C. Ogg]

    Eli Lilly and Co. (NYSE: LLY) also has a Neutral rating, and it was trading at $105.00. Merrill Lynch raised its price objective to $106 from $101, and the consensus analyst target price is $97.13.

  • [By Chris Lange]

    Eli Lilly and Co.’s (NYSE: LLY) short interest decreased to 12.64 million shares from the previous 14.20 million. The stock was trading at $106.21. The 52-week range is $73.69 to $107.84.

  • [By Chris Lange]

    Eli Lilly and Co. (NYSE: LLY) is set to report its most recent results Tuesday morning as well. The analysts’ consensus estimates are $1.14 in EPS on revenue of $5.49 billion. Shares were changing hands at $79.06 on Friday’s close. The consensus price target is $90.80, and the 52-week range is $73.69 to $89.09.

  • [By Ethan Ryder]

    Eli Lilly And Co (NYSE:LLY) major shareholder Lilly Endowment Inc sold 92,447 shares of the company’s stock in a transaction that occurred on Thursday, September 27th. The shares were sold at an average price of $107.00, for a total value of $9,891,829.00. Following the completion of the sale, the insider now owns 119,508,357 shares in the company, valued at approximately $12,787,394,199. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

  • [By Motley Fool Staff]

    Eli Lilly & Co. (NYSE:LLY) is a Goliath in diabetes treatment, and thanks to new drugs that can help patients control their disease better, the company’s diabetes sales are soaring.

Top 10 High Tech Stocks To Buy For 2019: Bellerophon Therapeutics, Inc.(BLPH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Radius Health (NASDAQ:RDUS) and Bellerophon Therapeutics (NASDAQ:BLPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

  • [By Money Morning Staff Reports]

    However, it’s unlikely Netlist repeats these returns anytime soon. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 230%…

    Penny Stock Current Share Price Last Week’s Gain
    Netlist Inc. (Nasdaq: NLST) $0.83 542.67%
    Mannkind Corp. (Nasdaq: MNKD) $1.80 79.09%
    Fred’s Inc. (Nasdaq: FRED) $2.49 73.68%
    Delcath Systems Inc. (OTCMKTS: DCTH) $3.70 72.63%
    Gemphire Therapeutics Inc. (Nasdaq: GEMP) $1.96 50.71%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $1.05 47.98%
    Cel-Sci Corp. (NYSE: CVM) $3.78 44.78%
    ParkerVision Inc. (OTCMKTS: PRKR) $0.60 29.42%
    Superior Drilling Products Inc. (NYSE: SDPI) $2.63 29.23%
    LiqTech International Inc. (NYSE: LIQT) $1.50 25.20%

    How to Profit off This $11.1 Billion Money Pool: By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month thanks to a genius investment. Learn more…

  • [By Stephan Byrd]

    Press coverage about Bellerophon Therapeutics (NASDAQ:BLPH) has trended somewhat positive on Thursday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bellerophon Therapeutics earned a news impact score of 0.14 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 46.948363531679 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 High Tech Stocks To Buy For 2019: Tejon Ranch Co(TRC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Terracoin (CURRENCY:TRC) traded down 14.6% against the dollar during the 24 hour period ending at 23:00 PM ET on May 17th. In the last week, Terracoin has traded 20.7% higher against the dollar. Terracoin has a market cap of $4.06 million and $4,377.00 worth of Terracoin was traded on exchanges in the last 24 hours. One Terracoin coin can now be bought for about $0.18 or 0.00002218 BTC on popular exchanges including CoinExchange, Trade Satoshi, C-CEX and Cryptopia.

  • [By Ethan Ryder]

    Terracoin (CURRENCY:TRC) traded up 10% against the dollar during the twenty-four hour period ending at 11:00 AM E.T. on October 8th. Terracoin has a total market cap of $2.09 million and approximately $4,720.00 worth of Terracoin was traded on exchanges in the last day. In the last seven days, Terracoin has traded down 15.3% against the dollar. One Terracoin coin can currently be bought for approximately $0.0910 or 0.00001375 BTC on popular exchanges including Trade Satoshi, CoinExchange, Cryptopia and C-CEX.

Top 10 High Tech Stocks To Buy For 2019: Orchids Paper Products Company(TIS)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at last week’s top-performing penny stocks, we’ll show you a penny stock on the verge of jumping over 159%…

    Penny Stock Current Share Price Last Week’s Gain
    My Size Inc. (NASDAQ: MYSZ) $1.19 60.71%
    Delcath Systems Inc. (OTCMKTS: DCTH) $3.21 52.38%
    Regional Health Properties Inc. (NYSE: RHE) $0.18 49.39%
    Nemaura Medical Inc. (NASDAQ: NMRD) $3.03 44.89%
    3Pea International Inc. (NASDAQ: TPNL) $4.62 42.24%
    PLx Pharma Inc. (NASDAQ: PLXP) $4.22 34.38%
    Orchids Paper Products Co. (NYSE: TIS) $3.99 34.30%
    DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) $0.74 33.41%
    Restoration Robotics Inc. (NASDAQ: HAIR) $3.08 32.74%
    Renren Inc. (NYSE: RENN) $1.69 32.61%

    Don’t Miss Out: The Treasury is sitting on an $11.1 billion cash pile, and a loophole entitles Americans to a sizable portion. Some are collecting $1,795, $3,000, or $5,000 every month thanks to this powerful investment…

  • [By Paul Ausick]

    Orchids Paper Products Co. (NYSEAMERICAN: TIS) dropped more than 12% Monday to set a new 52-week low of $0.70. Shares closed at $0.80 on Friday and the stock’s 52-week high is $15.47. Volume totaled around 15 million, about 60 times the daily average of around 250,000. The company had no specific news. Shares have made a massive comeback and are on track to close at $2.47, up more than 200%.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7
  • [By Money Morning Staff Reports]

    Last week’s top performing penny stock, Orchids Paper Products Co. (NYSE: TIS), jumped over 218% after the company delivered a stellar earnings reports on Aug. 13.

Top 10 High Tech Stocks To Buy For 2019: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Canlan Ice Sports Corp (TSE:ICE) declared a quarterly dividend on Friday, August 10th, Zacks reports. Stockholders of record on Friday, September 28th will be paid a dividend of 0.025 per share on Tuesday, October 16th. This represents a $0.10 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend is Thursday, September 27th. This is an increase from Canlan Ice Sports’s previous quarterly dividend of $0.02.

  • [By Joseph Griffin]

    Shares of Intercontinental Exchange (NYSE:ICE) have earned an average recommendation of “Buy” from the sixteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $78.36.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Intercontinental Exchange (ICE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    OTC Markets Group (OTCMKTS:OTCM) and Intercontinental Exchange (NYSE:ICE) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.

Top 10 High Tech Stocks To Buy For 2019: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jordan Wathen, Matthew Frankel, CFP, and Dan Caplinger]

    Below, three Motley Fool contributors lay the case for Cullen/Frost Bankers (NYSE:CFR), Morgan Stanley (NYSE:MS), and Synchrony Financial (NYSE:SYF) as ways to profit from a rising tide for bank stocks.

  • [By Anders Bylund, Jason Hall, Danny Vena, Jordan Wathen, and Brian Feroldi]

    In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giant Baidu (NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bank Cullen/Frost Bankers (NYSE:CFR).

  • [By Brian Feroldi]

    Cullen/Frost Bankers (NYSE:CFR), a regional bank based in Texas, reported its second-quarter results on Thursday, July 26. A favorable lending environment combined with rising interest rates to drive earnings-per-share growth of 30%.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 High Tech Stocks To Buy For 2019: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Guidewire Software (NYSE:GWRE) is scheduled to be announcing its earnings results after the market closes on Wednesday, September 5th. Analysts expect the company to announce earnings of $0.54 per share for the quarter.

  • [By Garrett Baldwin]

    Starbuck’s Corp. (Nasdaq: SBUX) Executive Chair Howard Schultz announced he will depart the company. Many are speculating he will pursue a career in politics and potentially seek the Democratic nomination for president in 2020. Schultz had previously denied any speculation around a role in government; but his recent comments suggest that “public service” will be a part of his future plans. Gold prices dipped below $1,300 per ounce as markets continue to speculate on the likelihood of additional interest rate hikes in 2018. We believe this is solid buying opportunity for investors. The reason why gold is going to get a nice boost: ongoing trade tensions between the United States and the rest of the globe. Money Morning Resource Specialist Peter Krauth provides his insight on where gold prices are heading next and how you can make big gains in the weeks ahead.
    Three Stocks to Watch Today: AAPL, TWTR, SCGLF
    Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the world’s first $1 trillion company. The stock pushed above $192.60 per share in pre-market hours after its first day at the Worldwide Developers Conference. During the event, the company unveiled its new mobile operating system, called iOS 12. The firm also unveiled a suite of tools designed to combat technology addiction. Shares of Twitter Inc. (NYSE: TWTR) jumped nearly 4% on news that the social media company is about to join the S&P 500. The company will join on Thursday morning and will replace agribusiness giant Monsanto Co. (NYSE: MON). The news comes as Monsanto is in the final steps of its merger with German chemical giant Bayer AG (Nasdaq: BAYRY). Shares of Societe Generale SA (ADR) (OTCMKTS: SCGLF) are in focus after the U.S. Justice Department announced the French investment bank will pay $1.3 billion to settle two ongoing legal headaches. The company bribed Libyan officials and manipulated LIBOR, a benchmark interest rate on which most financing is based. Legg Mason Inc. (NYSE: L

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Guidewire Software (GWRE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Guidewire Software Inc (NYSE:GWRE) shares reached a new 52-week high and low during mid-day trading on Wednesday . The company traded as low as $95.26 and last traded at $93.56, with a volume of 7356 shares changing hands. The stock had previously closed at $94.77.

Top 10 High Tech Stocks To Buy For 2019: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA’s review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
     Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11%
    Nano Dimension (Nasdaq: NNDM) $2.61 75.11%
    Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84%
    CLPS Inc. (Nasdaq: CLPS) $9.72 71.15%
    NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33%
    Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82%
    Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70%
    Polymet Mining Corp. (NYSE: PLM) $1.01 31.13%
    Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

    Many investors struggle with finding stocks with this sort of breakout potential because they don’t know where to look.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

Hot Financial Stocks To Own For 2019

News coverage about Precipio (NASDAQ:PRPO) has trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Precipio earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 47.5646752152396 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the media headlines that may have impacted Accern Sentiment’s analysis:

Get Precipio alerts:

Precipio Updates Commercial Pipeline for its ICE-COLD PCR Liquid Biopsy Technology (finance.yahoo.com) Financial Contrast: Precipio (PRPO) & Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) (americanbankingnews.com) Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders (markets.financialcontent.com) Precipio Inc (PRPO) Short Interest Update (americanbankingnews.com) Contrasting Bruker (BRKR) and Precipio (PRPO) (americanbankingnews.com)

Precipio traded down $0.03, hitting $0.44, during midday trading on Tuesday, according to MarketBeat.com. 897,281 shares of the company’s stock traded hands, compared to its average volume of 1,249,438. The company has a quick ratio of 0.12, a current ratio of 0.14 and a debt-to-equity ratio of 0.22. Precipio has a one year low of $0.36 and a one year high of $28.16.

Hot Financial Stocks To Own For 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Hot Financial Stocks To Own For 2019: AtriCure Inc.(ATRC)

Advisors’ Opinion:

  • [By Shane Hupp]

    ValuEngine upgraded shares of AtriCure (NASDAQ:ATRC) from a hold rating to a buy rating in a research report report published on Saturday.

    A number of other research firms have also weighed in on ATRC. Zacks Investment Research lowered shares of AtriCure from a buy rating to a hold rating in a report on Wednesday, May 2nd. BidaskClub raised shares of AtriCure from a hold rating to a buy rating in a report on Saturday, March 17th. Stifel Nicolaus raised their target price on shares of AtriCure from $22.00 to $23.00 and gave the company a buy rating in a report on Friday, April 27th. Needham & Company LLC raised their target price on shares of AtriCure from $23.00 to $26.00 and gave the company a buy rating in a report on Friday, April 27th. Finally, TheStreet raised shares of AtriCure from a d+ rating to a c- rating in a report on Friday, March 16th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of Buy and an average target price of $25.00.

Hot Financial Stocks To Own For 2019: Tsakos Energy Navigation Ltd(TNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Stifel Financial Corp lifted its stake in shares of TSAKOS ENERGY N/SH (NYSE:TNP) by 88.5% in the 1st quarter, Holdings Channel reports. The firm owned 392,994 shares of the shipping company’s stock after buying an additional 184,547 shares during the quarter. Stifel Financial Corp’s holdings in TSAKOS ENERGY N/SH were worth $1,301,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Tsakos Energy Navigation (TNP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Tsakos Energy Navigation (NYSE:TNP) Q1 2018 Earnings Conference CallJun. 15, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Casino Stocks To Buy For 2019

Warren Buffett warned students about the perils of using debt and leverage decades ago using Donald Trump as a negative case study.

Buffett was asked by a Notre Dame student about Trump’s business troubles during a question and answer session in 1991. Trump’s Atlantic City Taj Mahal casino filed for Chapter 11 bankruptcy protection later that year.

“Where did Donald Trump go wrong? The big problem with Donald Trump was he never went right. He basically overpaid for properties, but he got people to lend him the money. He was terrific at borrowing money. If you look at his assets, and what he paid for them, and what he borrowed to get them, there was never any real equity there,” Buffett said, according to a transcript published by former hedge fund manager Whitney Tilson. “I’ve seen more people fail because of liquor and leverage leverage being borrowed money. Donald Trump failed because of leverage. He simply got infatuated with how much money he could borrow, and he did not give enough thought to how much money he could pay back.”

Top 10 Casino Stocks To Buy For 2019: One Liberty Properties Inc.(OLP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) VP Justin Clair sold 3,100 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $25.00, for a total value of $77,500.00. Following the completion of the transaction, the vice president now directly owns 32,566 shares in the company, valued at $814,150. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Buy For 2019: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

  • [By Logan Wallace]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Top 10 Casino Stocks To Buy For 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Top 10 Casino Stocks To Buy For 2019: NV5 Global, Inc.(NVEE)

Advisors’ Opinion:

  • [By Logan Wallace]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NV5 Global (NVEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    NV5 Global (NASDAQ:NVEE) VP Richard Tong sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $66.40, for a total transaction of $66,400.00. Following the completion of the transaction, the vice president now owns 34,933 shares of the company’s stock, valued at $2,319,551.20. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Top 10 Casino Stocks To Buy For 2019: NewMarket Corporation(NEU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NewMarket (NEU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NewMarket (NEU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Neumark (CURRENCY:NEU) traded down 1.5% against the U.S. dollar during the one day period ending at 10:00 AM E.T. on June 8th. In the last seven days, Neumark has traded up 3.6% against the U.S. dollar. One Neumark token can now be purchased for about $0.39 or 0.00005083 BTC on popular exchanges including EtherDelta (ForkDelta), YoBit, Liqui and HitBTC. Neumark has a total market cap of $11.07 million and approximately $118,143.00 worth of Neumark was traded on exchanges in the last day.

Top 10 Casino Stocks To Buy For 2019: MER Telemanagement Solutions Ltd.(MTSL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News stories about MER Telemanagement Solutions (NASDAQ:MTSL) have trended somewhat positive on Sunday, according to Accern. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MER Telemanagement Solutions earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news articles about the technology company an impact score of 45.5243579518781 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 10 Casino Stocks To Buy For 2019: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Max Byerly]

    T. Rowe Price Group Inc (NASDAQ:TROW) Director Robert F. Maclellan sold 5,000 shares of T. Rowe Price Group stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $122.58, for a total value of $612,900.00. Following the completion of the transaction, the director now owns 13,769 shares in the company, valued at $1,687,804.02. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Casino Stocks To Buy For 2019: Computer Task Group, Incorporated(CTG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern’s scoring:

    Get Computer Task Group alerts:

    $88.05 Million in Sales Expected for Computer Task Group (CTG) This Quarter (americanbankingnews.com) CTG to Present at B. Riley Institutional Investor Conference on May 23 (finance.yahoo.com) Computer Task Group (CTG) Expected to Announce Earnings of $0.08 Per Share (americanbankingnews.com) ValuEngine Lowers Computer Task Group (CTG) to Hold (americanbankingnews.com)

    A number of brokerages recently commented on CTG. Zacks Investment Research lowered Computer Task Group from a “buy” rating to a “hold” rating in a research report on Friday, March 30th. ValuEngine lowered Computer Task Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Finally, Barrington Research reiterated a “hold” rating on shares of Computer Task Group in a research report on Friday, April 20th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $9.13.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Computer Task Group (CTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Buy For 2019: Westwood Holdings Group Inc(WHG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News coverage about Westwood Holdings Group (NYSE:WHG) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Westwood Holdings Group earned a coverage optimism score of 0.07 on Accern’s scale. Accern also assigned news stories about the asset manager an impact score of 46.2036320266502 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Casino Stocks To Buy For 2019: Pioneer Energy Services Corp.(PES)

Advisors’ Opinion:

  • [By Jason Hall]

    Shares of a handful of small independent oil and gas producers, as well as a number of smaller oilfield service and equipment providers fell more than 10% on May 25.Profire Energy, Inc.(NASDAQ:PFIE), which manufactures burner management systems for oil and gas companies, fell 14.5%, while offshore energy industry transportation specialistBristow Group Inc(NYSE:BRS) fell 12.6%. Onshore drilling contractorPioneer Energy Services Corp(NYSE:PES) and offshore oil and gas producerW&T Offshore, Inc.bothfell 11.4%, while independent oil and gas producersCalifornia Resources Corp (NYSE:CRC) andUltra Petroleum Corp(NASDAQ:UPL) fell 10.5% and 10%, respectively.

  • [By Shane Hupp]

    Seadrill Partners (NYSE: SDLP) and Pioneer Energy Services (NYSE:PES) are both small-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.

  • [By Shane Hupp]

    Pioneer Energy Services (NYSE:PES) Director C John Thompson sold 6,666 shares of Pioneer Energy Services stock in a transaction that occurred on Friday, May 4th. The stock was sold at an average price of $4.25, for a total transaction of $28,330.50. Following the completion of the transaction, the director now directly owns 41,818 shares in the company, valued at approximately $177,726.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

  • [By Max Byerly]

    GSA Capital Partners LLP raised its holdings in shares of Pioneer Energy Services (NYSE:PES) by 319.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 426,117 shares of the oil and gas company’s stock after acquiring an additional 324,588 shares during the quarter. GSA Capital Partners LLP owned approximately 0.55% of Pioneer Energy Services worth $1,151,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Pioneer Energy Services (NYSE: PES) and Key Energy Services (NYSE:KEG) are both small-cap oils/energy companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, profitability, institutional ownership, dividends and risk.

  • [By Stephan Byrd]

    TIAA CREF Investment Management LLC decreased its holdings in shares of Pioneer Energy Services (NYSE:PES) by 34.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,740 shares of the oil and gas company’s stock after selling 93,636 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.22% of Pioneer Energy Services worth $533,000 as of its most recent filing with the Securities and Exchange Commission.

Best Biotech Stocks To Invest In Right Now

Its time for the final push.

With only a handful of trading weeks remaining in 2017, little stands in the way of higher prices.

This years stock market melt-up has produced a long list of incredible winners. The FAANGs, semiconductors, and other big tech stocks have helped fuel the rally. Weve also had multiple chances to profit from the big biotech comeback and the rebirth of homebuilder stocks two more powerful market stories that have led to impressive gains this year.

Many of these stocks will continue to sneak higher during the holiday season. Once again, this rally rewards patient traders and investors who arent afraid to ride the markets most powerful trends.

But theres one group of stocks flying under the radar as melt-up season accelerates…

Unfortunately, many investors have a bad habit of ignoring some of the markets strongest plays simply because they dont know much about the companies responsible for the gains. Theyre caught up in the big narratives the media pipes into our skulls every day.

Best Biotech Stocks To Invest In Right Now: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Proteon Therapeutics Inc (NASDAQ: PRTO) got a boost, shooting up 31 percent to $1.70 after the company disclosed that it has received the FDA Breakthrough Therapy designation for Vonapanitase. Proteon Therapeutics posted a narrower-than-expected quarterly loss.

Best Biotech Stocks To Invest In Right Now: Opexa Therapeutics, Inc.(OPXA)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Opexa Therapeutics Inc (NASDAQ: OPXA) and Acer Therapeutics announced a merger that will result in 11.2-percent ownership by current Opexa shareholders and 88.8-percent ownership by current Acer shareholders.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares were also up, gaining 66 percent to $1.08 after the company announced plans to acquire Acer Therapeutics.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares dropped 70 percent to $1.02 after the company disclosed that its top-line results from Phase 2b Abili-T trial evaluating Tcelna did not meet primary endpoint.

Best Biotech Stocks To Invest In Right Now: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

Hot Casino Stocks To Own For 2018

Allegations that casino mogul Steve Wynn sexually harassed numerous employees at his Las Vegas resort may tilt the scales at the upcoming trial with his ex-wife, who claims she was booted off the company’s board for challenging his “reckless behavior."

“It’s a game changer," said Devin McRae, a litigator with Early Sullivan Wright Gizer & McRae in Los Angeles. “These allegations paint a picture of serious predation."

#lazy-img-323091068:before{padding-top:69.81818181818181%;}Elaine Wynn.Photographer: Gabe Ginsberg/Getty Images

Elaine Wynn, who has been fighting her ex-husband to gain control over her $1.8 billion stake in Wynn Resorts Ltd., claims she lost her board seat in 2015 because she raised questions about how Steve ran the company, including hiding from the board that he paid millions of dollars to settle misconduct claims by a former employee. Steve Wynn has denied the harassment allegations that were reported Friday by the Wall Street Journal.

Hot Casino Stocks To Own For 2018: EV Energy Partners, L.P.(EVEP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Hot Casino Stocks To Own For 2018: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Proteon Therapeutics Inc (NASDAQ: PRTO) got a boost, shooting up 31 percent to $1.70 after the company disclosed that it has received the FDA Breakthrough Therapy designation for Vonapanitase. Proteon Therapeutics posted a narrower-than-expected quarterly loss.

Hot Casino Stocks To Own For 2018: Ternium S.A.(TX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Ternium SA (NYSE:TX) jumped on Wednesday: up more than 10% by 2:30 p.m. EST. While the steelmaker reported weaker-than-expected earnings after the closing bell yesterday, it provided optimistic guidance and announced a compelling acquisition.

Hot Casino Stocks To Own For 2018: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Foreign Regional Banks: This industry declined 2 percent by 11:00 am with Bancolombia SA (ADR) (NYSE: CIB) moving down 3.7 percent. Bancolombia’s PEG ratio is 4.51.

  • [By Javier Hasse]

    Analysts at Credit Suisse downgraded shares of Bancolombia SA (ADR) (NYSE: CIB) from Outperform to Neutral, while boosting their price target from $38 to $40.

  • [By Monica Gerson]

    Bancolombia SA (ADR) (NYSE: CIB) is expected to post its quarterly earnings at $0.77 per share on revenue of $945.66 million.

    Cellcom Israel Ltd. (NYSE: CEL) is estimated to post its earnings for the latest quarter.

  • [By Matt Smith]

    Bancolombia appears attractively priced
    Another Colombian company that appears under-valued is the Andean country’s largest commercial bank Bancolombia (NYSE: CIB  ) . For the year-to-date Bancolombia’s share price fell 17% because of a weak second quarter bottom-line. This decline was primarily caused by the bank’s net income plunging by 41% year-over-year because of mark-to-market losses caused by the value lost in the bank’s securities portfolio.